Abbott Laboratories: Downgrade
St. Louis (www.aktiencheck.de) - Rating-Update:
Die Analysten von Edward Jones stufen die Aktie von Abbott Laboratories (ISIN: US0028241000, WKN: 850103, Ticker-Symbol:…
109,890€
1,69%
Echtzeit-Aktienkurs Abbott Laboratories
Bid:
Ask:
Nachrichten zur Abbott Laboratories Aktie
Abbott Laboratories: Kursziel 133 USD
San Francisco (www.aktiencheck.de) - Rating-Update:
Die Analysten von Wells Fargo Advisors stufen die Aktie von Abbott Laboratories (ISIN: US0028241000, WKN: 850103,…
Abbott Laboratories: Kursziel verbessert
London (www.aktiencheck.de) - Rating-Update:
Die Analysten von Barclays stufen die Aktie von Abbott Laboratories (ISIN: US0028241000, WKN: 850103, Ticker-Symbol: ABL, NYSE-Symbol…
Abbott Laboratories: Strafe im Bereich der möglichen erwarteten Ergebnisse -Aktienanalyse
Charlotte (www.aktiencheck.de) - Abbott Laboratories-Aktienanalyse von BofA Securities:
Die Analysten von BofA Securities raten in einer aktuellen Aktienanalyse weiterhin zum Kauf…
Abbott Laboratories down 5% premarket on baby formula verdict
Shares of Abbott Laboratories (NYSE:ABT) were marked 5% lower in pre-market trading after a Missouri jury awarded $495 million in a…
Investors brace for busy week, McDonald’s earnings miss estimates: Yahoo Finance
Stocks are starting the day higher, kicking off a busy week on Wall Street. On the economic front, investors will…
Abbott Laboratories: Aktie fällt stark - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Abbott Laboratories-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…
Abbott und Reckitt massiv unter Druck: Das ist der Grund
Die Aktie des amerikanischen Diagnostik-Spezialisten Abbott Laboratories steht zum Beginn der neuen Handelswoche massiv unter Druck und zieht auch das…
Abbott und Reckitt massiv unter Druck: Das ist der Grund
Die Aktie des amerikanischen Diagnostik-Spezialisten Abbott Laboratories steht zum Beginn der neuen Handelswoche massiv unter Druck und zieht auch das…
Reckitt Benckiser shares slammed by US infant formula litigation read-across
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) shares tumbled 7.5% on Monday morning after a litigation decision in the US against Abbott…
Barclays hebt Ziel für Reckitt auf 5815 Pence - Overweight
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Reckitt minimal von 5800 auf 5815 Pence angehoben…
Abbott must pay $95 million in premature infant formula trial, jury finds
A jury on Friday found that Abbott Laboratories specialized formula for premature infants caused an Illinois girl to develop a…
Better Buy: Abbott Laboratories vs. Intuitive Surgical @themotleyfool #stocks $ABT $ISRG
The medical technology business has been good for both companies, but which is right for your portfolio?…
Better Buy: Abbott Laboratories vs. Intuitive Surgical
The medical technology business has been good for both companies, but which is right for your portfolio?…
Top Analyst Reports for SAP, Abbott Laboratories & Citigroup
Todays Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), Abbott Laboratories (ABT) and Citigroup…
Global Consumer Health Market Size To Worth USD 713.92 Billion By 2033 | CAGR Of 7.34%
The Global Consumer Health Market Size was Valued at USD 351.46 Billion in 2023 and the Worldwide Consumer Health Market…
Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
ABT earnings call for the period ending June 30, 2024.…
Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
…
Abbott raises annual profit forecast as strong medical device sales power quarterly beat
Abbott Laboratories raised its annual profit forecast on Thursday and beat Wall Street estimates for second-quarter earnings, buoyed by strong…
Abbott Laboratories: When Double-Digit Device Growth Apparently Isnt Enough
…
Heres How Abbott (ABT) is Placed Ahead of Q2 Earnings Release
Abbott Laboratories (ABT) second-quarter 2024 results are likely to reflect broad-based strength across several businesses and solid progress in the…
Abbott Laboratories: The Fantastic Mix Of Growth And Value - At A Great Price
…
Global Precision Diagnostics Market Size To Worth USD 254.48 Billion By 2033 | CAGR Of 13%
The Global Precision Diagnostics Market Size was Valued at USD 74.98 Billion in 2023 and the Worldwide Precision Diagnostics Market…
Global Cancer Diagnostics Market Size To Exceed USD 323.17 Billion By 2033 | CAGR of 8.71%
The Global Cancer Diagnostics Market Size was Valued at USD 140.25 Billion in 2023 and the Worldwide Cancer Diagnostics Market…
Global Cardiac Prosthetic Devices Market Size To Exceed USD 14.4 Billion By 2033 | CAGR Of 8.11%
The Global Cardiac Prosthetic Devices Market Size was Valued at USD 6.6 Billion in 2023 and the Worldwide Cardiac Prosthetic…
Abbott Laboratories: Abpraller nach oben - Chartanalyse
Paris (www.aktiencheck.de) - Abbott Laboratories: Abpraller nach oben - Chartanalyse
Die Abbott Laboratories-Aktie (ISIN: US0028241000, WKN: 850103, Ticker-Symbol: ABL, NYSE-Symbol ABT)…
Global Tissue Diagnostics Market Size To Worth USD 10.8 Billion By 2033 | CAGR of 8.22%
The Global Tissue Diagnostics Market Size was Valued at USD 4.9 Billion in 2023 and the Worldwide Tissue Diagnostics Market…
Global Parkinson’s Disease Treatment Market Size To Worth USD 9.14 Billion By 2033 | CAGR Of 6.41%
The Global Parkinsons Disease Treatment Market Size was Valued at USD 4.91 Billion in 2023 and the Worldwide Parkinsons Disease…
The Zacks Analyst Blog Highlights Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine
Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine are included in this Analyst Blog.…
Abbott Laboratories: Umkehrformation - Chartanalyse
Paris (www.aktiencheck.de) - Abbott Laboratories: Umkehrformation - Chartanalyse
Die Aktie von Abbott Laboratories (ISIN: US0028241000, WKN: 850103, Ticker-Symbol: ABL, NYSE-Symbol ABT)…
Top Analyst Reports for Abbott, BP & Gilead
Todays Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BP p.l.c. (BP) and Gilead…
Global Anal Fissure Treatment Market Size To Exceed USD 1986.1 Million By 2033 | CAGR Of 5.51%
The Global Anal Fissure Treatment Market Size was Valued at USD 1161.3 Million in 2023 and the Worldwide Anal Fissure…
Global Companion Diagnostics Market Size To Exceed USD 23.12 Billion By 2033 | CAGR Of 12.50%
The Global Companion Diagnostics Market Size was Valued at USD 7.12 Billion in 2023 and the Worldwide Companion Diagnostics Market…
Abbott Laboratories declares $0.55 dividend
…
Abbott Laboratories: Vor Hochlauf - Chartanalyse
Paris (www.aktiencheck.de) - Abbott Laboratories: Vor Hochlauf - Chartanalyse
Die Abbott Laboratories-Aktie (ISIN: US0028241000, WKN: 850103, Ticker-Symbol: ABL, NYSE-Symbol ABT) befindet…
Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%
The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…
Global Prostate Health Market Size To Worth USD 78.03 Billion By 2033 | CAGR Of 9.12%
The Global Prostate Health Market Size was Valued at USD 32.6 Billion in 2023 and the Worldwide Prostate Health Market…
Abbott Wins FDA Approval For Two Over-The-Counter Diabetes Trackers
Abbott Laboratories said the U.S. Food and Drug Administration has cleared for sale two new over-the-counter continuous glucose monitoring systems.…
Abbott Laboratories: Why I Agree With Wall Street On This One
…
NYSE Glitch Halts About a Dozen Stocks In Error
An apparent glitch at the operator of the New York Stock Exchange triggered volatility trading halts shortly after the open…
Global Dyspepsia Drugs Market Size To Worth Exceed USD 14.7 Billion By 2033 | CAGR Of 4.46%
The Global Dyspepsia Drugs Market Size was Valued at USD 9.5 Billion in 2023 and the Worldwide Dyspepsia Drugs Market…
Investing in Abbott Laboratories (NYSE:ABT) five years ago would have delivered you a 46% gain
Abbott Laboratories ( NYSE:ABT ) shareholders might be concerned after seeing the share price drop 12% in the last...…
Global Minimally Invasive Surgical Instrument Market Size To Exceed USD 70.5 Billion By 2033 | CAGR of 8.74%
The Global Minimally Invasive Surgical Instrument Market Size was Valued at USD 30.5 Billion in 2023 and the Worldwide Minimally…
Top Stock Reports for UnitedHealth, Danaher & Abbott
Todays Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Danaher Corporation (DHR) and…
Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock
…
Drug Device Combination Products Market Worth Over $180 Billion by 2029 - Medtronic, Abbott Laboratories, and Boston Scientific Corporation Dominate the Industry
Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Drug Device Combination Products Market - Global Industry Size, Share,…
Abbott Laboratories: Kursziel gekappt
London (www.aktiencheck.de) - Rating-Update:
Die Analysten von Barclays stufen die Aktie von Abbott Laboratories (ISIN: US0028241000, WKN: 850103, Ticker-Symbol: ABL, NYSE-Symbol…
Analyst Report: Abbott Laboratories
…
Cardiac Marker Industry Trends, Opportunities, and Competitive Landscape 2018-2033: Features Profiles of Abbott Laboratories, Siemens, Danaher Corporation, bioMerieux, and Roche
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Cardiac Marker Global Market Report 2024" report has been added…
Global Cardiovascular Surgical Devices Market Expected to Surge to US$ 2.77 Billion by 2032 - Technological Innovations and Approvals Boosting the Market
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Cardiovascular Surgical Devices Market, Size, Share, Global Forecast 2024-2032, Industry…